Ariad grants ReGenX exclusive rights to Argent's gene cell-signaling regulation technology for human therapeutics and vaccines

Ariad Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

ReGenX Biosciences LLC

U.S. / Tools, Services, and Manufacturing

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced